# Role of the Liver in Glucose Homeostasis Using Metabolic Imaging

> **NCT04352738** · — · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 30 (actual)

## Conditions studied

- Type 1 Diabetes
- Bariatric Surgery Candidate

## Interventions

- **DIAGNOSTIC_TEST:** Multiparametric, multinuclear MR (DMI/ 13C-MRS/ GlycoCEST/GlycoNOE)

## Key facts

- **NCT ID:** NCT04352738
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-15
- **Primary completion:** 2022-04-21
- **Final completion:** 2022-08-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04352738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04352738, "Role of the Liver in Glucose Homeostasis Using Metabolic Imaging". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04352738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*